ID CBG_HUMAN Reviewed; 405 AA. AC P08185; A8K456; Q7Z2Q9; DT 01-AUG-1988, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1988, sequence version 1. DT 24-JAN-2024, entry version 214. DE RecName: Full=Corticosteroid-binding globulin; DE Short=CBG; DE AltName: Full=Serpin A6; DE AltName: Full=Transcortin; DE Flags: Precursor; GN Name=SERPINA6; Synonyms=CBG; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Liver, and Lung; RX PubMed=3299377; DOI=10.1073/pnas.84.15.5153; RA Hammond G.L., Smith C.L., Goping I.S., Underhill D.A., Harley M.J., RA Reventos J., Musto N.A., Gunsalus G.L., Bardin C.W.; RT "Primary structure of human corticosteroid binding globulin, deduced from RT hepatic and pulmonary cDNAs, exhibits homology with serine protease RT inhibitors."; RL Proc. Natl. Acad. Sci. U.S.A. 84:5153-5157(1987). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3386241; DOI=10.1016/0022-4731(88)90085-4; RA Bardin C.W., Gunsalus G.L., Musto N.A., Cheng C.Y., Reventos J., Smith C., RA Underhill D.A., Hammond G.; RT "Corticosteroid binding globulin, testosterone-estradiol binding globulin, RT and androgen binding protein belong to protein families distinct from RT steroid receptors."; RL J. Steroid Biochem. 30:131-139(1988). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Liver; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-246. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 23-30. RX PubMed=3347061; DOI=10.1016/0022-4731(88)90268-3; RA Kato E.A., Hsu B.R.-S., Kuhn R.W.; RT "Comparative structural analyses of corticosteroid binding globulin."; RL J. Steroid Biochem. 29:213-220(1988). RN [7] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-96. RC TISSUE=Plasma; RX PubMed=14760718; DOI=10.1002/pmic.200300556; RA Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; RT "Screening for N-glycosylated proteins by liquid chromatography mass RT spectrometry."; RL Proteomics 4:454-465(2004). RN [8] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-31; ASN-96; ASN-330 AND RP ASN-369. RC TISSUE=Plasma; RX PubMed=16335952; DOI=10.1021/pr0502065; RA Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., RA Smith R.D.; RT "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, RT hydrazide chemistry, and mass spectrometry."; RL J. Proteome Res. 4:2070-2080(2005). RN [9] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-96 AND ASN-330. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [10] RP X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 33-405 IN COMPLEX WITH CORTISOL, RP FUNCTION, AND DOMAIN. RX PubMed=18513745; DOI=10.1016/j.jmb.2008.05.012; RA Zhou A., Wei Z., Stanley P.L., Read R.J., Stein P.E., Carrell R.W.; RT "The S-to-R transition of corticosteroid-binding globulin and the mechanism RT of hormone release."; RL J. Mol. Biol. 380:244-251(2008). RN [11] RP VARIANT CBG DEFICIENCY HIS-115. RX PubMed=1504007; DOI=10.1016/0960-0760(92)90107-t; RA Smith C.L., Power S.G.A., Hammond G.L.; RT "A Leu-->His substitution at residue 93 in human corticosteroid binding RT globulin results in reduced affinity for cortisol."; RL J. Steroid Biochem. Mol. Biol. 42:671-676(1992). RN [12] RP VARIANT CBG DEFICIENCY HIS-115. RX PubMed=8212073; DOI=10.1016/0039-128x(93)90072-u; RA van Baelen H., Power S.G.A., Hammond G.L.; RT "Decreased cortisol-binding affinity of transcortin Leuven is associated RT with an amino acid substitution at residue-93."; RL Steroids 58:275-277(1993). RN [13] RP VARIANT CBG DEFICIENCY ASN-389. RX PubMed=10634411; DOI=10.1210/jcem.85.1.6315; RA Emptoz-Bonneton A., Cousin P., Seguchi K., Avvakumov G.V., Bully C., RA Hammond G.L., Pugeat M.; RT "Novel human corticosteroid-binding globulin variant with low cortisol- RT binding affinity."; RL J. Clin. Endocrinol. Metab. 85:361-367(2000). RN [14] RP VARIANT CBG DEFICIENCY ASN-389. RX PubMed=17245537; DOI=10.1007/s00702-006-0620-5; RA Buss C., Schuelter U., Hesse J., Moser D., Phillips D.I., Hellhammer D., RA Meyer J.; RT "Haploinsufficiency of the SERPINA6 gene is associated with severe muscle RT fatigue: A de novo mutation in corticosteroid-binding globulin RT deficiency."; RL J. Neural Transm. 114:563-569(2007). CC -!- FUNCTION: Major transport protein for glucocorticoids and progestins in CC the blood of almost all vertebrate species. CC {ECO:0000269|PubMed:18513745}. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Plasma; synthesized in liver. Has also been CC identified in a number of glycocorticoid responsive cells. CC -!- DOMAIN: Proteolytic cleavage leads to an important conformation change. CC This reduces the affinity for steroids. {ECO:0000269|PubMed:18513745}. CC -!- PTM: N-glycosylated; binds 5 oligosaccharide chains. CC -!- PTM: Glycosylation in position Asn-260 is needed for steroid binding. CC -!- DISEASE: Corticosteroid-binding globulin deficiency (CBG deficiency) CC [MIM:611489]: Extremely rare hereditary disorder characterized by CC reduced corticosteroid-binding capacity with normal or low plasma CC corticosteroid-binding globulin concentration, and normal or low basal CC cortisol levels associated with hypo/hypertension and muscle fatigue. CC {ECO:0000269|PubMed:10634411, ECO:0000269|PubMed:1504007, CC ECO:0000269|PubMed:17245537, ECO:0000269|PubMed:8212073}. Note=The CC disease is caused by variants affecting the gene represented in this CC entry. CC -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Wikipedia; Note=Transcortin entry; CC URL="https://en.wikipedia.org/wiki/Transcortin"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J02943; AAB59523.1; -; mRNA. DR EMBL; AK290821; BAF83510.1; -; mRNA. DR EMBL; CH471061; EAW81568.1; -; Genomic_DNA. DR EMBL; BC056259; AAH56259.1; -; mRNA. DR EMBL; BC058021; AAH58021.1; -; mRNA. DR CCDS; CCDS9924.1; -. DR PIR; A28321; A28321. DR RefSeq; NP_001747.2; NM_001756.3. DR PDB; 2VDX; X-ray; 1.84 A; A/B=33-357, A/B=372-405. DR PDB; 2VDY; X-ray; 2.30 A; A/B=33-405. DR PDB; 4BB2; X-ray; 2.48 A; A=33-371, B=372-405. DR PDB; 4C41; X-ray; 1.80 A; A=33-405. DR PDB; 4C49; X-ray; 2.70 A; A/B/C/D=33-405. DR PDBsum; 2VDX; -. DR PDBsum; 2VDY; -. DR PDBsum; 4BB2; -. DR PDBsum; 4C41; -. DR PDBsum; 4C49; -. DR AlphaFoldDB; P08185; -. DR SMR; P08185; -. DR BioGRID; 107314; 14. DR IntAct; P08185; 3. DR STRING; 9606.ENSP00000342850; -. DR BindingDB; P08185; -. DR ChEMBL; CHEMBL2421; -. DR DrugBank; DB00240; Alclometasone. DR DrugBank; DB00394; Beclomethasone dipropionate. DR DrugBank; DB00443; Betamethasone. DR DrugBank; DB14669; Betamethasone phosphate. DR DrugBank; DB01222; Budesonide. DR DrugBank; DB01410; Ciclesonide. DR DrugBank; DB01013; Clobetasol propionate. DR DrugBank; DB09130; Copper. DR DrugBank; DB01380; Cortisone acetate. DR DrugBank; DB05688; CRx-119. DR DrugBank; DB00687; Fludrocortisone. DR DrugBank; DB00663; Flumethasone. DR DrugBank; DB00180; Flunisolide. DR DrugBank; DB00591; Fluocinolone acetonide. DR DrugBank; DB01047; Fluocinonide. DR DrugBank; DB00324; Fluorometholone. DR DrugBank; DB00846; Flurandrenolide. DR DrugBank; DB13867; Fluticasone. DR DrugBank; DB08906; Fluticasone furoate. DR DrugBank; DB00588; Fluticasone propionate. DR DrugBank; DB00741; Hydrocortisone. DR DrugBank; DB14538; Hydrocortisone aceponate. DR DrugBank; DB14539; Hydrocortisone acetate. DR DrugBank; DB14540; Hydrocortisone butyrate. DR DrugBank; DB14541; Hydrocortisone cypionate. DR DrugBank; DB14542; Hydrocortisone phosphate. DR DrugBank; DB14543; Hydrocortisone probutate. DR DrugBank; DB14544; Hydrocortisone valerate. DR DrugBank; DB09124; Medrogestone. DR DrugBank; DB00253; Medrysone. DR DrugBank; DB00648; Mitotane. DR DrugBank; DB01384; Paramethasone. DR DrugBank; DB00860; Prednisolone. DR DrugBank; DB15566; Prednisolone acetate. DR DrugBank; DB14631; Prednisolone phosphate. DR DrugBank; DB00635; Prednisone. DR DrugBank; DB00896; Rimexolone. DR DrugBank; DB00620; Triamcinolone. DR DrugBank; DB00596; Ulobetasol. DR DrugBank; DB01593; Zinc. DR DrugBank; DB14487; Zinc acetate. DR DrugBank; DB14533; Zinc chloride. DR DrugBank; DB14548; Zinc sulfate, unspecified form. DR DrugCentral; P08185; -. DR MEROPS; I04.954; -. DR GlyConnect; 788; 20 N-Linked glycans (5 sites). DR GlyCosmos; P08185; 7 sites, 33 glycans. DR GlyGen; P08185; 7 sites, 32 N-linked glycans (5 sites), 2 O-linked glycans (1 site). DR iPTMnet; P08185; -. DR PhosphoSitePlus; P08185; -. DR BioMuta; SERPINA6; -. DR DMDM; 115851; -. DR CPTAC; CPTAC-717; -. DR CPTAC; non-CPTAC-2661; -. DR CPTAC; non-CPTAC-2662; -. DR jPOST; P08185; -. DR MassIVE; P08185; -. DR MaxQB; P08185; -. DR PaxDb; 9606-ENSP00000342850; -. DR PeptideAtlas; P08185; -. DR ProteomicsDB; 52081; -. DR ABCD; P08185; 1 sequenced antibody. DR Antibodypedia; 59; 555 antibodies from 40 providers. DR CPTC; P08185; 1 antibody. DR DNASU; 866; -. DR Ensembl; ENST00000341584.4; ENSP00000342850.3; ENSG00000170099.6. DR Ensembl; ENST00000621384.2; ENSP00000484501.1; ENSG00000277405.2. DR GeneID; 866; -. DR KEGG; hsa:866; -. DR MANE-Select; ENST00000341584.4; ENSP00000342850.3; NM_001756.4; NP_001747.3. DR UCSC; uc001ycv.4; human. DR AGR; HGNC:1540; -. DR CTD; 866; -. DR DisGeNET; 866; -. DR GeneCards; SERPINA6; -. DR HGNC; HGNC:1540; SERPINA6. DR HPA; ENSG00000170099; Tissue enriched (liver). DR MalaCards; SERPINA6; -. DR MIM; 122500; gene. DR MIM; 611489; phenotype. DR neXtProt; NX_P08185; -. DR OpenTargets; ENSG00000170099; -. DR Orphanet; 199247; Corticosteroid-binding globulin deficiency. DR PharmGKB; PA35033; -. DR VEuPathDB; HostDB:ENSG00000170099; -. DR eggNOG; KOG2392; Eukaryota. DR GeneTree; ENSGT00940000161611; -. DR HOGENOM; CLU_023330_2_1_1; -. DR InParanoid; P08185; -. DR OMA; HDSELPC; -. DR OrthoDB; 3218836at2759; -. DR PhylomeDB; P08185; -. DR TreeFam; TF343201; -. DR PathwayCommons; P08185; -. DR Reactome; R-HSA-194002; Glucocorticoid biosynthesis. DR Reactome; R-HSA-9757110; Prednisone ADME. DR SignaLink; P08185; -. DR BioGRID-ORCS; 866; 9 hits in 1148 CRISPR screens. DR ChiTaRS; SERPINA6; human. DR EvolutionaryTrace; P08185; -. DR GeneWiki; Transcortin; -. DR GenomeRNAi; 866; -. DR Pharos; P08185; Tchem. DR PRO; PR:P08185; -. DR Proteomes; UP000005640; Chromosome 14. DR RNAct; P08185; Protein. DR Bgee; ENSG00000170099; Expressed in liver and 46 other cell types or tissues. DR ExpressionAtlas; P08185; baseline and differential. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; HDA:UniProtKB. DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:GO_Central. DR GO; GO:0005496; F:steroid binding; IDA:UniProtKB. DR GO; GO:0008211; P:glucocorticoid metabolic process; IEA:Ensembl. DR CDD; cd19554; serpinA6_CBG; 1. DR Gene3D; 2.30.39.10; Alpha-1-antitrypsin, domain 1; 1. DR Gene3D; 3.30.497.10; Antithrombin, subunit I, domain 2; 1. DR InterPro; IPR023795; Serpin_CS. DR InterPro; IPR023796; Serpin_dom. DR InterPro; IPR000215; Serpin_fam. DR InterPro; IPR036186; Serpin_sf. DR InterPro; IPR042178; Serpin_sf_1. DR InterPro; IPR042185; Serpin_sf_2. DR PANTHER; PTHR11461:SF34; CORTICOSTEROID-BINDING GLOBULIN; 1. DR PANTHER; PTHR11461; SERINE PROTEASE INHIBITOR, SERPIN; 1. DR Pfam; PF00079; Serpin; 1. DR PRINTS; PR00780; LEUSERPINII. DR SMART; SM00093; SERPIN; 1. DR SUPFAM; SSF56574; Serpins; 1. DR PROSITE; PS00284; SERPIN; 1. DR Genevisible; P08185; HS. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Disease variant; Glycoprotein; KW Lipid-binding; Reference proteome; Secreted; Signal; Steroid-binding; KW Transport. FT SIGNAL 1..22 FT /evidence="ECO:0000269|PubMed:3347061" FT CHAIN 23..405 FT /note="Corticosteroid-binding globulin" FT /id="PRO_0000032429" FT BINDING 254 FT /ligand="cortisol" FT /ligand_id="ChEBI:CHEBI:17650" FT /evidence="ECO:0000269|PubMed:18513745, FT ECO:0007744|PDB:2VDY" FT BINDING 286 FT /ligand="cortisol" FT /ligand_id="ChEBI:CHEBI:17650" FT /evidence="ECO:0000269|PubMed:18513745, FT ECO:0007744|PDB:2VDY" FT BINDING 390 FT /ligand="cortisol" FT /ligand_id="ChEBI:CHEBI:17650" FT /evidence="ECO:0000269|PubMed:18513745, FT ECO:0007744|PDB:2VDY" FT BINDING 393 FT /ligand="cortisol" FT /ligand_id="ChEBI:CHEBI:17650" FT SITE 250 FT /note="Conserved cysteine within steroid binding domain" FT CARBOHYD 31 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952" FT CARBOHYD 96 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:14760718, FT ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218" FT CARBOHYD 176 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 260 FT /note="N-linked (GlcNAc...) asparagine" FT CARBOHYD 330 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952, FT ECO:0000269|PubMed:19159218" FT CARBOHYD 369 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952" FT VARIANT 115 FT /note="L -> H (in CBG deficiency; Leuven; decreased FT cortisol-binding affinity; dbSNP:rs113418909)" FT /evidence="ECO:0000269|PubMed:1504007, FT ECO:0000269|PubMed:8212073" FT /id="VAR_007111" FT VARIANT 246 FT /note="S -> A (in dbSNP:rs2228541)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_024350" FT VARIANT 389 FT /note="D -> N (in CBG deficiency; Lyon; decreased FT cortisol-binding affinity; dbSNP:rs28929488)" FT /evidence="ECO:0000269|PubMed:10634411, FT ECO:0000269|PubMed:17245537" FT /id="VAR_016223" FT HELIX 39..57 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 59..61 FT /evidence="ECO:0007829|PDB:2VDX" FT STRAND 63..65 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 67..78 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 83..92 FT /evidence="ECO:0007829|PDB:4C41" FT TURN 97..99 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 102..117 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 119..122 FT /evidence="ECO:0007829|PDB:4C49" FT STRAND 123..134 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 141..151 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 154..158 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 163..177 FT /evidence="ECO:0007829|PDB:4C41" FT TURN 178..180 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 188..190 FT /evidence="ECO:0007829|PDB:4BB2" FT STRAND 194..209 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 213..215 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 217..224 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 227..244 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 246..257 FT /evidence="ECO:0007829|PDB:4C41" FT TURN 258..260 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 261..268 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 273..279 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 282..291 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 293..302 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 304..311 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 313..318 FT /evidence="ECO:0007829|PDB:4C41" FT HELIX 323..325 FT /evidence="ECO:0007829|PDB:4C41" FT TURN 332..334 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 336..338 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 340..353 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 355..370 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 375..378 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 383..389 FT /evidence="ECO:0007829|PDB:4C41" FT TURN 390..393 FT /evidence="ECO:0007829|PDB:4C41" FT STRAND 394..402 FT /evidence="ECO:0007829|PDB:4C41" SQ SEQUENCE 405 AA; 45141 MW; F0E36EFC3B3C08A1 CRC64; MPLLLYTCLL WLPTSGLWTV QAMDPNAAYV NMSNHHRGLA SANVDFAFSL YKHLVALSPK KNIFISPVSI SMALAMLSLG TCGHTRAQLL QGLGFNLTER SETEIHQGFQ HLHQLFAKSD TSLEMTMGNA LFLDGSLELL ESFSADIKHY YESEVLAMNF QDWATASRQI NSYVKNKTQG KIVDLFSGLD SPAILVLVNY IFFKGTWTQP FDLASTREEN FYVDETTVVK VPMMLQSSTI SYLHDSELPC QLVQMNYVGN GTVFFILPDK GKMNTVIAAL SRDTINRWSA GLTSSQVDLY IPKVTISGVY DLGDVLEEMG IADLFTNQAN FSRITQDAQL KSSKVVHKAV LQLNEEGVDT AGSTGVTLNL TSKPIILRFN QPFIIMIFDH FTWSSLFLAR VMNPV //